Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

AVALIAÇÃO COGNITIVA E COMPLICAÇÕES PÓS-OPERATÓRIAS APÓS CIRURGIA: LIGANDO ANESTESIA E RISCO (CAPSULAR)

21 de setembro de 2026 atualizado por: University of Edinburgh

AVALIAÇÃO COGNITIVA E COMPLICAÇÕES PÓS-OPERATÓRIAS APÓS CIRURGIA: LIGANDO A ANESTESIA E O RISCO

Many older people can experience confusion, memory problems, or a decline in their thinking after major surgery. These problems are sometimes called 'postoperative neurocognitive disorders' or PND and can affect recovery and a person's ability to live independently.

The investigators want to find out the best way to study these problems in older patients undergoing surgery. This is a 'feasibility study', which means we are testing the research methods. The investigators want to see if it is possible to ask participants to do memory tests and give blood samples before and after their operation. The investigators are hoping to include around 40 patients over 2 years in this study.

The investigators will compare performance in memory (cognitive assessment) findings before and after surgery and link this to data taken from the anaesthetic, including the types of drugs used, duration, brain features from processed electroencephalogram monitoring and standard recommended monitoring. In addition the investigators will link this to blood sample markers of brain health and function (biomarkers).

The results of this study will help the investigators plan a much larger study in the future, with the ultimate goal of making surgery safer for the brain.

Visão geral do estudo

Descrição detalhada

SUMMARY

Older patients can experience significant difficulties with memory and thinking (known as cognitive problems) after major surgery. The specific reasons in this vulnerable group are not yet clearly understood.

CAPSULAR is a single-centre feasibility research project at the Western General Hospital, Edinburgh, that aims to find the best way to conduct detailed research into this problem.

Objectives:

Main Aim:

- To determine if it is practical and feasible to screen older participants (age ≥ 70) for cognitive problems both before surgery and up to 7 days after surgery (or before leaving hospital, if earlier).

Secondary Aims:

  • Collect extra blood samples (at the same time as routine clinical blood tests) to measure markers of potential brain injury. These will be collected before, immediately after, and up to 7 days after surgery (or before leaving hospital, if earlier).
  • Gather detailed data on the participant's health, frailty, and the anaesthetic technique used, including standard brain monitoring (pEEG) to monitor anaesthesia depth during the operation.
  • Look for a link between anaesthesia technique and the risk of cognitive problems and blood markers of brain injury.
  • Proxy outcomes to inform economic analysis in a larger planned trial e.g. impact on changes in care need, cognitive aids such as new use of a multi-compartment drug compliance aid.

We plan to recruit 40 patients aged ≥ 70 who are scheduled for colorectal or urological surgery lasting over one hour. Participants will be those already attending the POPS (Perioperative Medicine for Older People undergoing Surgery) clinic.

The study will measure success based on the percentage of eligible patients who agree to take part, complete the one-week cognitive screening, and provide all the necessary blood and data samples.

This research will provide the crucial initial evidence needed to plan future definitive trials exploring whether altering anaesthetic or surgical care can safely reduce brain problems for older and frailer patients.

2 INTRODUCTION

2.1 BACKGROUND

Postoperative neurocognitive disorders (PND) represent a spectrum of cognitive impairments that can arise after surgery, ranging from acute, reversible, postoperative delirium to more persistent, and sometimes subtle, cognitive decline. These disorders are particularly common in older adults, with reported incidence rates for postoperative delirium as high as 40% following major elective surgery. The consequences are significant, including prolonged hospital stays, increased patient morbidity and mortality, and a greater likelihood of long-term cognitive impairment, which can profoundly reduce a patient's quality of life and independence. Additionally, there may be further impact economically and upon the formal and informal care sectors for example new dependence on aids.

The investigators' previous work with the Perioperative Care for Older People Undergoing Surgery (POPS) Clinic at the Western General Hospital, Edinburgh, identified that 21% of patients scheduled for major surgery had previously unrecognised pre-operative cognitive impairment. This cohort subsequently experienced a high incidence of PND, particularly delirium, affecting 40% of those who underwent emergency surgery and 5% of those undergoing elective surgery. This highlights a vulnerable patient population in whom the risks of postoperative cognitive decline are substantial.

The pathophysiology of PND is thought to be multifactorial, involving interplay between patient-specific risk factors (e.g., advanced age, frailty, pre-existing cognitive deficits) and procedural factors, such as surgical stress, systemic inflammation, and anaesthetic technique. Previous research has often included younger and less frail individuals, leaving a critical knowledge gap concerning those elderly and frailer patients who are possibly most at risk.

Given the increasing trend towards older patients undergoing major surgery, there is therefore, an urgent need for research focused specifically on elderly and frail patients to identify reliable risk factors. This includes physiological and molecular biomarkers predictive of PND. This knowledge will enable us to better identify at-risk patients to inform consent, guide preventative resources, and stratify participants for future trials of therapeutic interventions.

2.2 RATIONALE FOR STUDY

One near-universal criticism of the existing literature in this area has been that study cohorts have not been of a sufficiently advanced age. The investigators' research location hospital and clinic stream enables them to set recruitment at 70 years of age or over, as one in five, over-75 year olds, are predicted to undergo surgery from 2030.

While the pilot data established a high incidence of PND in a high-risk cohort, the investigators now need to investigate and categorise the nature of PND with greater accuracy and determine if it is feasible to robustly investigate the impact of perioperative factors on cognitive outcomes.

This project aims to address this evidence gap. The investigators will conduct a prospective feasibility study to establish the practicalities of performing detailed, domain-specific cognitive testing in a high-risk, frail, older patient population at baseline (preoperatively) and postoperatively. This will allow them to accurately quantify the incidence of new or worsening cognitive impairment following major surgery. Furthermore, the investigators will assess the feasibility of systematically collecting detailed data on anaesthetic technique, including intra-operative processed EEG metrics, and obtaining serial blood samples for biomarker analysis. Finally the investigators will assess proxy- patient impact and economic markers such as predicted vs. actual length of stay, change to living arrangements and provision of new aids.

The investigators hypothesize that it is feasible to recruit this cohort and perform these detailed assessments. This work is critical as it will provide the foundational data necessary to design a larger, adequately powered trial to determine whether specific anaesthetic practices, such as pEEG-guided anaesthesia to minimise burst suppression, can mitigate the risk of long-lasting postoperative cognitive decline in vulnerable patients. It will inform the design of research aimed at generating data to help identify at-risk patients, possibly identify modifiable factors and quantify the incidence which would help improve the accuracy of pre-surgery counselling.

Tipo de estudo

Observacional

Inscrição (Estimado)

40

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Kieran P Nunn, MB BS, BSc(h), FRCA, FFICM
  • Número de telefone: +441315371652
  • E-mail: kieran.nunn@nhs.scot

Estude backup de contato

  • Nome: Zoeb Jiwaji, MBBCh, PhD, MRCP, FRCA, FFICM
  • Número de telefone: +441315371652
  • E-mail: zoeb.jiwaji@ed.ac.uk

Locais de estudo

    • Midlothian
      • Edinburgh, Midlothian, Reino Unido, EH4 2XU
        • Western General Hospital
        • Contato:
          • Kieran P Nunn, MBBS, BSc (hons), FRCA, FFICM
          • Número de telefone: +441315371652
          • E-mail: kieran.nunn@nhs.scot
        • Contato:
        • Subinvestigador:
          • Helen Jones, MBChB

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

70 anos e mais velhos (Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra de Probabilidade

População do estudo

We will conduct a prospective, single-centre feasibility cohort study over a period of 24 months, recruiting patients from the Perioperative medicine for Older People having Surgery clinic (POPS) clinic at the Western General Hospital, Edinburgh, who are scheduled for major surgery. This is a pre-surgery clinic and physician-led inpatient follow up service with discharge planning roles. Note, the nature of the clinical pathway means that patients may wait several months from POPS clinic review until surgery.

Descrição

Inclusion Criteria:

  • Age ≥ 70
  • Seen in the Perioperative medicine for Older People undergoing Surgery (POPS) clinic
  • Scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes

Exclusion Criteria:

  • Regional anaesthesia only
  • Planned day surgery or expected hospital stay < 24 hours
  • Expected to remain sedated and ventilated for > 24 hours postoperatively
  • Participant does not wish to remain in the study if capacity is lost during the study

CO-ENROLMENT

  • As this is a non-intervention study, co-enrolment will be permitted in other studies that do not conflict with this protocol.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: COHORT
  • Perspectivas de Tempo: PROSPECTIVE

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Perioperative medicine for Older People undergoing Surgery (POPS) clinic patients

Age > 70, scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes.

Preoperative and Postoperative MoCA

  • Pre-operatively: sample collected at a suitable time of blood draw for routine peri-operative clinical samples or insertion of a peripheral venous cannula as part of routine anaesthetic care after consent and enrollment. This may be in the POPS clinic or on day of admission for surgery or when canulated for anaesthesia.
  • Immediate post-operative period: sample collected in recovery or on the ward at the first ordered routine blood-draw.
  • Up to 7 days post-surgery: sample collected on the ward (or last anticipated routine sample).

Biomarkers assessed will be a panel linked to brain injury, inflammation, and cognitive impairment in non-ICU populations.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
The proportion of eligible patients who consent to participate and are successfully screened for delayed neurocognitive recovery up to discharge or 7 days, whichever is sooner.
Prazo: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The primary outcome assesses the proportion of eligible patients who consent and then undergo pre- and post-operative cognitive testing.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
The proportion of consented patients from whom a complete set of blood samples (pre-anaesthesia, post-anaesthesia, and up to discharge or 7 days, whichever is sooner) is successfully collected and stored.
Prazo: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then provide pre-, immediately-post-operative and pre-discharge biomarker blood samples (additional tubes/samples from routine blood-lets).

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The proportion of consented patients for whom complete anaesthetic data, including depth of anaesthesia parameters, are successfully retrieved from electronic records.
Prazo: The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then have a complete intraoperative data-set collected.

The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The incidence and nature of PND identified through domain-specific cognitive testing.
Prazo: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Analysis of the performance in the Montreal Cognitive Assessment (MoCA) tool allows us to both analyse incidence, but also features of, any identified cognitive changes across the timespan of the patients preparation and undertaking of surgery.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
New functional dependence at hospital discharge as identified by change in home social support or requirement for aids (e.g. Dossette box).
Prazo: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

New support for independent living or new dependence will be recorded at the point the patient leaves the study in order to better understand this and plan for the economic impact analysis in a future study.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Colaboradores

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

1 de março de 2028

Conclusão do estudo (Estimado)

1 de março de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

10 de março de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de março de 2026

Primeira postagem (Real)

13 de março de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

24 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

21 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever